ATE291080T1 - Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden - Google Patents

Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden

Info

Publication number
ATE291080T1
ATE291080T1 AT97953093T AT97953093T ATE291080T1 AT E291080 T1 ATE291080 T1 AT E291080T1 AT 97953093 T AT97953093 T AT 97953093T AT 97953093 T AT97953093 T AT 97953093T AT E291080 T1 ATE291080 T1 AT E291080T1
Authority
AT
Austria
Prior art keywords
gene
compositions
methods
polypeptides encoded
human lipase
Prior art date
Application number
AT97953093T
Other languages
English (en)
Inventor
Michael C Jaye
Kim-Anh Thi Doan
John A Krawiec
Kevin J Lynch
Dilip V Amin
Victoria J South
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE291080T1 publication Critical patent/ATE291080T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT97953093T 1996-12-06 1997-12-05 Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden ATE291080T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3278396P 1996-12-06 1996-12-06
US3225496P 1996-12-06 1996-12-06
PCT/US1997/022331 WO1998024888A2 (en) 1996-12-06 1997-12-05 Polypeptides encoded by a human lipase-like gene, compositions and methods

Publications (1)

Publication Number Publication Date
ATE291080T1 true ATE291080T1 (de) 2005-04-15

Family

ID=26708180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97953093T ATE291080T1 (de) 1996-12-06 1997-12-05 Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden

Country Status (22)

Country Link
US (4) US6395530B1 (de)
EP (1) EP0948609B1 (de)
JP (2) JP4615634B2 (de)
KR (1) KR100516561B1 (de)
CN (2) CN100497610C (de)
AP (1) AP1313A (de)
AT (1) ATE291080T1 (de)
AU (1) AU750891B2 (de)
BG (1) BG64798B1 (de)
BR (1) BR9713847A (de)
CA (1) CA2273823C (de)
CZ (1) CZ299055B6 (de)
DE (2) DE69732789T2 (de)
EA (1) EA003293B1 (de)
ES (1) ES2239367T3 (de)
HK (2) HK1024929A1 (de)
IL (2) IL129986A0 (de)
NO (1) NO326140B1 (de)
OA (1) OA11057A (de)
PL (1) PL191624B1 (de)
SK (1) SK287687B6 (de)
WO (1) WO1998024888A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008776B1 (en) * 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
CZ299055B6 (cs) * 1996-12-06 2008-04-09 Aventis Pharmaceuticals Inc. Izolovaný polypeptid kódovaný genem podobným genupro lipázu, prostredek mající fosfolipázovou úcinnost, farmaceutický prostredek, izolovaný imunizacní peptid a nukleová kyselina, biologicky aktivní prostredek, vektor, rekombinantní bunka, prostredek
US7692067B2 (en) * 2002-09-18 2010-04-06 Mendel Biotechnology, Inc. Yield and stress tolerance in transgenic plants
WO2000057837A2 (en) * 1999-03-26 2000-10-05 Aventis Pharmaceuticals Products Inc. Compositions and methods for effecting the levels of cholesterol
GB9920334D0 (en) 1999-08-28 1999-11-03 Glaxo Group Ltd Method
US6337187B1 (en) * 1999-11-05 2002-01-08 Millennium Pharmaceuticals, Inc. 18891, a novel human lipase
AU1361601A (en) * 1999-11-05 2001-05-14 Millennium Pharmaceuticals, Inc. 18892, a novel human lipase
WO2002024898A2 (en) * 2000-09-25 2002-03-28 Millennium Pharmaceuticals, Inc. 47647, a human lipase and uses therefor
US7507808B2 (en) * 2002-12-12 2009-03-24 Isis Pharmaceuticals, Inc. Modulation of endothelial lipase expression
CN102250854B (zh) * 2011-07-01 2013-03-27 浙江商达环保有限公司 用于处理油脂污染物的脂肪酶、编码基因及其应用
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
MA41035A (fr) * 2014-08-19 2017-08-15 Shire Human Genetic Therapies Lipoprotéine lipase pour le traitement d'affections liées à une hypertriglycéridémie, y compris la pancréatite aiguë
TWI688575B (zh) * 2014-09-11 2020-03-21 日商塩野義製藥股份有限公司 阻礙血管內皮脂酶之酵素活性的人類化單株抗體

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
FR2573436B1 (fr) 1984-11-20 1989-02-17 Pasteur Institut Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
JP2764264B2 (ja) 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5364777A (en) 1992-04-03 1994-11-15 American Air Liquide Method of improving lipase activity using noble gases
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
DK88892D0 (da) 1992-07-06 1992-07-06 Novo Nordisk As Forbindelse
DE69334095T2 (de) 1992-07-17 2007-04-12 Dana-Farber Cancer Institute, Boston Verfahren zur intrazellulären Bindung von zielgerichteten Molekülen
US5998189A (en) * 1992-12-16 1999-12-07 Warner-Lambert Company Polypeptide derivatives of dog gastric lipase and pharmaceutical compositions containing same
DK0687300T3 (da) * 1993-03-05 2001-12-31 Univ Catholique Louvain LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
FR2704556B1 (fr) 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
FR2705686B1 (fr) 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
FR2706486B1 (fr) 1993-06-16 1995-09-01 Rhone Poulenc Rorer Sa Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
SK282843B6 (sk) 1993-07-13 2002-12-03 Rhone-Poulenc Rorer S. A. Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
AU1806795A (en) 1994-02-22 1995-09-04 Novo Nordisk A/S A method of preparing a variant of a lipolytic enzyme
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
ES2236738T3 (es) 1995-05-31 2005-07-16 Medzyme N.V. Composicion para mejorar la digestibilidad y la utilizacion de nutrientes.
US7008776B1 (en) 1996-12-06 2006-03-07 Aventis Pharmaceuticals Inc. Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
CZ299055B6 (cs) 1996-12-06 2008-04-09 Aventis Pharmaceuticals Inc. Izolovaný polypeptid kódovaný genem podobným genupro lipázu, prostredek mající fosfolipázovou úcinnost, farmaceutický prostredek, izolovaný imunizacní peptid a nukleová kyselina, biologicky aktivní prostredek, vektor, rekombinantní bunka, prostredek
WO1999032611A1 (en) 1997-12-19 1999-07-01 Progenitor, Inc. A lipase expressed in endothelial cells and methods for its use
US6337187B1 (en) * 1999-11-05 2002-01-08 Millennium Pharmaceuticals, Inc. 18891, a novel human lipase
US6558936B1 (en) * 1999-10-01 2003-05-06 Millennium Pharmaceuticals, Inc. Human lipase proteins, nucleic acids encoding them, and uses of both of these

Also Published As

Publication number Publication date
EA199900522A1 (ru) 2000-02-28
EP0948609B1 (de) 2005-03-16
WO1998024888A3 (en) 1998-08-13
DE69732789D1 (de) 2005-04-21
HK1024929A1 (en) 2000-10-27
IL129986A (en) 2006-07-05
JP2010284171A (ja) 2010-12-24
CN1240000A (zh) 1999-12-29
WO1998024888A2 (en) 1998-06-11
AU5690598A (en) 1998-06-29
US20030108538A1 (en) 2003-06-12
KR100516561B1 (ko) 2005-09-22
US6395530B1 (en) 2002-05-28
US20120114660A1 (en) 2012-05-10
CZ9902003A3 (cs) 2000-10-11
BG64798B1 (bg) 2006-04-28
JP5416053B2 (ja) 2014-02-12
US7579447B2 (en) 2009-08-25
US20070101451A1 (en) 2007-05-03
KR20000069336A (ko) 2000-11-25
JP4615634B2 (ja) 2011-01-19
NO992735L (no) 1999-08-05
CA2273823A1 (en) 1998-06-11
SK287687B6 (sk) 2011-06-06
AP1313A (en) 2004-10-04
CZ299055B6 (cs) 2008-04-09
EA003293B1 (ru) 2003-04-24
US8343494B2 (en) 2013-01-01
DE948609T1 (de) 2000-03-09
PL191624B1 (pl) 2006-06-30
AU750891B2 (en) 2002-08-01
ES2239367T3 (es) 2005-09-16
AP9901548A0 (en) 1999-06-30
CN1167793C (zh) 2004-09-22
CA2273823C (en) 2007-06-05
CN1539849A (zh) 2004-10-27
NO992735D0 (no) 1999-06-04
BR9713847A (pt) 2000-02-29
HK1068636A1 (en) 2005-04-29
OA11057A (en) 2002-03-08
EP0948609A2 (de) 1999-10-13
US7056720B2 (en) 2006-06-06
DE69732789T2 (de) 2005-08-11
SK75399A3 (en) 2001-02-12
IL129986A0 (en) 2000-02-29
BG103472A (en) 2001-01-31
NO326140B1 (no) 2008-10-06
CN100497610C (zh) 2009-06-10
JP2001505769A (ja) 2001-05-08

Similar Documents

Publication Publication Date Title
NO20100324L (no) Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid
IL161016A (en) Polypeptides capable of ang-2 binding
CA2258502A1 (en) Modified factor viii
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
TR200100056T2 (tr) Nörotrofik faktörler
HK1068636A1 (en) Polypeptides encoded by a human lipase-like gene, compositions and methods
ATE378375T1 (de) Methoden und zusammensetzungen zum wirksameren abfangen von sauerstoff
DE59710609D1 (de) Mittel zur Herstellung von Leder
EP1004674A4 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
DE69839566D1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
ATE221537T1 (de) Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung
WO1998042739A3 (en) Secreted proteins and polynucleotides encoding them
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DE69938130D1 (de) Neue peptide
WO1998037094A3 (en) Secreted proteins and polynucleotides encoding them
PE20399A1 (es) Muteina ob
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
DK1045914T3 (da) Testis-specifik human SVPH1-8 proteinase
EP0964701A4 (de) Leptin-protein aus rindern, die dafür kodierende nukleinsäuresequenz und ihre verwendungsmöglichkeiten
WO1998030696A8 (en) Secreted proteins and polynucleotides encoding them
DE69820903D1 (de) Sprach-kodierungs-verfahren und endgeräte zum implementieren besagten verfahrens
WO1998024905A3 (en) Secreted proteins and polynucleotides encoding them
WO1998001553A3 (en) Secreted proteins and polynucleotides encoding them
NO20006091D0 (no) Humant protein C-polypeptid
DE69841861D1 (de) E immunomodulatoren und entsprechende methoden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties